Trial Profile
Study of the mechanisms of Gleevec resistance in CML [chronic myeloid leukaemia] patients
Status:
Not stated
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 14 Dec 2005
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 14 Dec 2005 New trial record.